Bicycle Therapeutics plc Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Bicycle Therapeutics plc (BCYC) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -3.70% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-03-17
- Bicycle Therapeutics plc effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was -3.70%.
- Bicycle Therapeutics plc effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was -0.60%.
- Bicycle Therapeutics plc effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was -0.40%.
- Bicycle Therapeutics plc effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was -0.60%, a 166.67% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -3.70% 10-K · filed 2026-03-17 | |
| 2023-12-31 | -0.60% 10-K · filed 2026-03-17 | -0.30% 10-K · filed 2024-02-20 |
| 2022-12-31 | -0.40% 10-K · filed 2025-02-25 | 0.30% 10-K · filed 2023-02-28 |
| 2021-12-31 | -0.60% 10-K · filed 2024-02-20 | 0.60% 10-K · filed 2022-03-01 |
| 2020-12-31 | 0.90% 10-K · filed 2023-02-28 | |
| 2019-12-31 | 1.30% 10-K · filed 2022-03-01 | |
| 2018-12-31 | 1.10% 10-K · filed 2021-03-11 | |
| 2017-12-31 | 0.40% 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |